Search Results

Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC–derived striatal neurons

• Authors : Bunting, Emma L; Donaldson, Jasmine; Cumming, Sarah A

• Source: Science Translational Medicine , 17 (785) , Article eadn4600. (2025)

Record details

Huntington’s disease alters human neurodevelopment.

• Authors : Barnat, Monia; Capizzi, Mariacristina; Aparicio, Esther

• Source: Science. 8/14/2020, Vol. 369 Issue 6505, p787-793. 7p. 4 Diagrams.

Record details

CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease

• Authors : Picó, Sara; Parras, Alberto; Santos Galindo, María

Subjects: Corea de Huntington; Vitamines B; Huntington's disease

• Source: Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Record details

Treating early postnatal circuit defect delays Huntington's disease onset and pathology in mice.

• Authors : Braz BY; Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France.; Wennagel D

Subjects: Brain*/Brain*/Brain*/abnormalities ; Huntingtin Protein*/Huntingtin Protein*/Huntingtin Protein*/genetics ; Huntington Disease*/Huntington Disease*/Huntington Disease*/embryology

• Source: Science (New York, N.Y.) [Science] 2022 Sep 23; Vol. 377 (6613), pp. eabq5011. Date of Electronic Publication: 2022 Sep 23.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease.

• Authors : Zuccato, Chiara; Ciammola, Andrea; Rigamonti, Dorotea

• Source: Science. 7/20/2001, Vol. 293 Issue 5529, p493-498. 6p. 4 Graphs.

Record details

An early start to Huntington's disease.

• Authors : DiFiglia M; Laboratory of Cellular Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. .

Subjects: Huntington Disease*; Humans ; Neuropsychological Tests

• Source: Science (New York, N.Y.) [Science] 2020 Aug 14; Vol. 369 (6505), pp. 771-772.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

Sp 1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease.

• Authors : Dunah, Anthone W.; Hyunkyung Jeong; Griffin, April

• Source: Science. 6/21/2002, Vol. 296 Issue 5576, p2238-2243. 6p. 4 Graphs.

Record details

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease

• Authors : Brogueira Rodrigues, F; Byrne, L; Tortelli, R

• Source: Science Translational Medicine , 12 (574) (2020)

Record details

Inactivation of the mouse Huntington's disease gene homolog Hdh.

• Authors : Duyao, Mabel P.; Auerbach, Anna B.

• Source: Science. 7/21/1995, Vol. 269 Issue 5222, p407. 4p. 6 Color Photographs, 3 Black and White Photographs, 1 Diagram, 1 Chart.

Record details

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease

• Authors : Byrne, LM; Brogueira Rodrigues, F; Johnson, E

• Source: Science Translational Medicine , 10 (458) , Article eaat7108. (2018)

Record details